Cardiothoracic & vascular anesthesia

Robustness of Randomized Controlled Trials Evaluating Acute Normovolemic Hemodilution as a Blood Conservation Strategy in Cardiac Surgery

J Cardiothorac Vasc AnesthPublished Systematic review of randomised controlled trials

Authors' conclusion

RCTs reporting significant reductions in red blood cell transfusions with ANH exhibited greater statistical robustness, as indicated by higher FI and CFI values, compared with nonsignificant studies.

Study context

Population
Adults undergoing cardiac surgery28 RCTs
Comparison
Acute normovolemic hemodilution (ANH) vs standard care
Methodological detailsFragility Index analysis, Search of PubMed/MEDLINE, Cochrane Central Register of Controlled Trials and EMBASE from inception
  • Fragility Index analysis
  • Search of PubMed/MEDLINE, Cochrane Central Register of Controlled Trials and EMBASE from inception

Pooled result

As reported in the abstract

  • Median Fragility Index (FI) for perioperative transfusion rates higher in nonsignificant studies (p ≥ 0.05) than in significant ones (p < 0.05)
  • Median Continuous FI (CFI) for number of RBC units transfused higher in significant studies

Further pooled results

Trial characteristics

Median sample size (patients)
75.8
On-pump CABG, most common procedure
39.3%

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Robustness of Randomized Controlled Trials Evaluating Acute Normovolemic Hemodilution as a Blood Conservation Strategy in Cardiac Surgery. J Cardiothorac Vasc Anesth. Published 1 July 2025. doi:10.1053/j.jvca.2025.06.051

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.